The Consumer Product Safety Commission (CPSC) has announced a Chronic Hazard Advisory Panel (CHAP) teleconference regarding the effects of phthalates and phthalate substitutes on children’s health. The November 15, 2010,teleconference, to be followed by meetings on December 2 and 3, will include discussion of possible risk assessment approaches.
CPSC appointed this CHAP under the Consumer Product Safety Improvement Act of 2008 to study the effects on children’s health of all phthalates and phthalate alternatives used in children’s toys and child care articles. The law “permanently prohibits” sales of such products containing “more than 0.1 percent of each of three specified phthalates: Di- (2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP).” The law also prohibits, on an interim basis, the sale of any ‘‘children’s toy that can be placed in a child’s mouth’’ or ‘‘child care article’’ containing “more than 0.1 percent of each of three additional phthalates: diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate (DnOP).”
CHAP is required to, among other matters, (i) “examine all of the potential health effects (including endocrine disrupting effects) of the full range of phthalates”; (ii) “examine the likely levels of children’s, pregnant women’s, and others’ exposure to phthalates, based on a reasonable estimation of normal and foreseeable use and abuse of such products”; (iii) “review all relevant data, including the most recent, best-available, peer-reviewed, scientific studies”; and (iv) “consider the level at which there is a reasonable certainty of no harm to children, pregnant women, or other susceptible individuals and their offspring, considering the best available science, and using sufficient safety factors to account for uncertainties regarding exposure and other potentially susceptible individuals.” See Federal Register, November 3, 2010.